ALI ANWAR: Open Payments
NPI 1710328703 · ELGIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,580 in 78 payments from 16 companies in 2025. Trend: 2023 $932 · 2024 $542 · 2025 $1,580
Food & beverage: $1,580
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 17 | $317 |
| ABBVIE INC. | 11 | $237 |
| E.R. Squibb & Sons, L.L.C. | 12 | $188 |
| Axsome Therapeutics, Inc. | 5 | $161 |
| Lundbeck LLC | 7 | $135 |
| Teva Pharmaceuticals USA, Inc. | 6 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Janssen Pharmaceuticals, Inc | 2 | $53 |
| Tris Pharma Inc | 3 | $52 |
Products named: INGREZZA, VRAYLAR, COBENFY, ABILIFY ASIMTUFII, Auvelity, AUSTEDO XR, CAPLYTA, REXULTI.
Industry payments across IL — which companies pay providers there.
